Y Combinator’s biotech startups incubate a new generation of therapies and tools
TechCrunch
MARCH 24, 2021
Medical and biotech had a strong showing at Y Combinator’s latest demo day , with nearly a dozen companies in the space catching my eye. LiliumX is taking the algorithmic approach to generating potential antibody stuctures that could be effective, as many AI-informed biotech companies have before it. Startups take on big pharma.
Let's personalize your content